American Society of Hematology

Fig. 3.

Fig. 3. DFS from CR of patients randomized to chemotherapy with or without GM-CSF. N, number of patients; O, observed number of relapses/deaths.

DFS from CR of patients randomized to chemotherapy with or without GM-CSF. N, number of patients; O, observed number of relapses/deaths.

This Feature Is Available To Subscribers Only

Sign In or Create an Account